American Oncology Network, Inc.
American Oncology Network, Inc. (AONC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
aonc · pe ratio · data through Dec 31, 2024
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for American Oncology Network, Inc. (AONC) measures how much investors pay for each dollar of the company's trailing earnings. AONC's current PE ratio of N/A is calculated by dividing its stock price of $12.00 by its TTM earnings per share of -$0.29.
Source: FMP · /ratios-ttm · /analyst-estimates · 2024-12-31
PE Ratio History
2020 – 2024 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Care Facilities · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
American Oncology Network, Inc.You AONC | $351M | N/A | — | -$0.29 |
 Benchmark Holdings plc BHCCF | $225M | N/A | — | -$0.05 |
 3-D Matrix, Ltd. DMTRF | $270M | N/A | — | -$25.20 |
 China Evergrande New Energy Vehicle Group Limited EVGRF | $2M | N/A | — | -$1.10 |
 Hansa Biopharma AB (publ) HNSBF | $246M | N/A | — | -$6.58 |
 Mayne Pharma Group Limited MAYNF | $126M | N/A | — | -$1.14 |
 Medical Facilities Corporation MFCSF | $230M | 10.50x | — | $1.08 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2024-12-31Latest FY2024 | — | $-0.29 | — | |
2023-12-31 FY2023 | — | $-0.83 | — | |
2022-12-31 FY2022 | 161.82x | $0.06 | — | |
2021-12-31 FY2021 | — | $-0.00 | — | |
2020-12-31 FY2020 | 13.06x | $0.74 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for American Oncology Network, Inc. (AONC) measures how much investors pay for each dollar of the company's trailing earnings. AONC's current PE ratio of N/A is calculated by dividing its stock price of $12.00 by its TTM earnings per share of -$0.29.
Frequently asked questions
AONC pe ratio · 6 questionsAONC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $12.00 and TTM EPS of -$0.29. Data sourced from Financial Modeling Prep via AONC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · American Oncology Network, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09